Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415202 · ClinicalTrials.gov registry record
Remimazolam Sedation for Nerve Blocks
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 100
- Enrollment target
NCT05415202 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 100 participants.
The verdict
NCT05415202 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Observational study recording sedation and safety of patients undergoing remimazolam sedation for peripheral nerve blocks. Objectives: To explore the safety and efficacy of remimazolam for neuraxial procedures and peripheral nerve pre-blocks and re-blocks. Patients undergoing epidurals, fascial plane blocks, and peripheral nerve blocks will receive remimazolam for sedation. Specific outcomes to assess include: depth of sedation, length of sedation, presence of apnea, presence of nausea/vomiting/other side effects, if the sedation was sufficient for the procedure. Assessment methods: MOAAS - Modified Observer's Assessment of Alertness and Sedation score Subjective patient report Vital signs Time for recovery Side effects Hypothesis: Remimazolam provides short-acting, adequate and safe sedation for peripheral nerve blocks in the ambulatory setting.
Interventions
- DRUG Remimazolam 20 MG [Byfavo]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2022-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05415202
The ClinicalTrials.gov registry entry for NCT05415202 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remimazolam 20 MG [Byfavo] is the first listed.
NCT05415202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05415202 about?
NCT05415202 is a clinical study titled "Remimazolam Sedation for Nerve Blocks". Observational study recording sedation and safety of patients undergoing remimazolam sedation for peripheral nerve blocks. Objectives: To explore the safety and efficacy of remimazolam for neuraxial procedures and peripheral nerve pre-blocks and re-blocks. Patients undergoing epidurals, fascial p...
What is the current status of trial NCT05415202?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2022-06-06. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT05415202?
The interventions under investigation include: Remimazolam 20 MG [Byfavo] (DRUG).
Who is sponsoring clinical trial NCT05415202?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.